Survivin as a Preferential Target for Cancer Therapy

By Mobahat Mahsa   Narendran Aru   Riabowol Karl  

International Journal of Molecular Sciences, Vol. 15, Iss. 2, 2014-02 ,pp. : 2494-2516

MDPI

Access to resources Recommend Favorite

Mitochondrial Peroxiredoxin III is a Potential Target for Cancer Therapy

By Song In-Sung   Kim Hyoung-Kyu   Jeong Seung-Hun   Lee Sung-Ryul   Kim Nari   Rhee Byoung Doo   Ko Kyung Soo   Han Jin  

International Journal of Molecular Sciences, Vol. 12, Iss. 10, 2011-10 ,pp. : 7163-7185

MDPI

Access to resources Recommend Favorite

Protein Kinase C: An Attractive Target for Cancer Therapy

By Marengo Barbara   De Ciucis Chiara   Ricciarelli Roberta   Pronzato Maria A.   Marinari Umberto M.   Domenicotti Cinzia  

Cancers, Vol. 3, Iss. 1, 2011-02 ,pp. : 531-567

MDPI

Access to resources Recommend Favorite

Molecular Approaches To Target GPCRs in Cancer Therapy

By Innamorati Giulio   Valenti Maria Teresa   Giovinazzo Francesco   Carbonare Luca Dalle   Parenti Marco   Bassi Claudio  

Pharmaceuticals, Vol. 4, Iss. 4, 2011-03 ,pp. : 567-589

MDPI

Access to resources Recommend Favorite

Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives

By Dufour Marc   Dormond-Meuwly Anne   Demartines Nicolas   Dormond Olivier  

Cancers, Vol. 3, Iss. 2, 2011-05 ,pp. : 2478-2500

MDPI

Access to resources Recommend Favorite